Trials / Unknown
UnknownNCT04470921
STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- Female
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to optimize implementation of the opportunistic salpingectomy throughout the Netherlands.
Detailed description
The investigators aim to optimize implementation of opportunistic salpingectomy throughout the Netherlands. The investigators will evaluate the implementation by enrolling patients in a database to evaluate healthcare experiences and to register EOC diagnosis and vital status through yearly PALGA (the nationwide network and registry of histopathology and cytopathology in the Netherlands) and municipal administration searches. In addition, the investigators will perform medical record check to assess which percentage of eligible women have been offered OS. The investigators expect that a decision aid will be a necessary tool for the decision whether women opt for an OS or not, based on their personal values. After development of the tool(s), the investigators will evaluate the implementation process.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Opportunistic Salpingectomy | An opportunistic salpingectomy refers to removal of the fallopian tubes without the ovaries during (laparoscopic) interventions for benign (gynaecological) disease to reduce the number of ovarian cancer cases. |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2025-01-01
- Completion
- 2025-12-31
- First posted
- 2020-07-14
- Last updated
- 2024-01-26
Locations
27 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04470921. Inclusion in this directory is not an endorsement.